(Q39254062)

10 September 2017

title

The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP). (English)

1 reference

10 September 2017

1 reference

chronic rhinosinusitis

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28429305%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Gretchen M Oakley

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28429305%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Valerie J Lund

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28429305%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

1 May 2017

1 reference

Current Allergy and Asthma Reports

10 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28429305%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28429305%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28429305%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28429305%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells by 11 different ketolide antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Anti-inflammatory effects of macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

The role of cytokines in infectious sinusitis and nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Macrolide antibiotics protect against endotoxin-induced vascular leakage and neutrophil accumulation in rat trachea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

The effects of macrolides on inflammatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin: mechanisms of action and their relevance for clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin for prevention of exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin--review of key chemical, pharmacokinetic and microbiological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Drug induced QT prolongation and torsades de pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Oral erythromycin and the risk of sudden death from cardiac causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Cardiovascular outcomes associated with use of clarithromycin: population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Macrolide antibiotics and the risk of cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Intersubject and dose-related variability after intravenous administration of erythromycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Comparative pharmacokinetics of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Erythromycin-induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Killing of Streptococcus pneumoniae by azithromycin, clarithromycin, erythromycin, telithromycin and gemifloxacin using drug minimum inhibitory concentrations and mutant prevention concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Early postoperative care following endoscopic sinus surgery: an evidence-based review with recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

International Consensus Statement on Allergy and Rhinology: Rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Structured histopathology profiling of chronic rhinosinusitis in routine practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Management of the upper airway in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Association between severity of asthma and degree of chronic rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Upper and lower airways associations in patients with chronic rhinosinusitis and bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Asthma phenotypes: the evolution from clinical to molecular approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Evaluation of the improvement of quality of life with Azithromycin in the treatment of eosinophilic nasal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Medical Therapies for Adult Chronic Sinusitis: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Azithromycin add-on therapy in high-risk postendoscopic sinus surgery patients failing corticosteroid irrigations: A clinical practice audit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Macrolide therapy for chronic rhinosinusitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

Drug interactions and hepatitis produced by some macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11882-017-0696-Z

A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis

21 January 2018

1 reference

12 December 2020

The efficacy of clarithromycin in patients with severe nasal polyposis.

1 reference

12 December 2020

EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

1 reference

12 December 2020

Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis

1 reference

12 December 2020

Systemic and topical antibiotics for chronic rhinosinusitis

1 reference

12 December 2020

Erythromycin pharmacokinetics in man

1 reference

12 December 2020

Inhibitory Effect of Macrolides on Interleukin‐8 Secretion From Cultured Human Nasal Epithelial Cells

1 reference

12 December 2020

Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells

1 reference

12 December 2020

Long-term postoperative azithromycin in patients with chronic rhinosinusitis: A randomized clinical trial

1 reference

12 December 2020

Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis

1 reference

12 December 2020

Optimal duration of macrolide treatment for chronic sinusitis after endoscopic sinus surgery

1 reference

12 December 2020

Effect of clarithromycin and azithromycin on production of cytokines by human monocytes

1 reference

12 December 2020

Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy

1 reference

12 December 2020

Clinical implications of the immunomodulatory effects of macrolides

1 reference

12 December 2020

Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy

1 reference

12 December 2020

Leukotriene B4 in Bronchoalveolar Lavage Fluid of Patients With Diffuse Panbronchiolitis

1 reference

12 December 2020

[Clinical pharmacokinetics of azithromycin]

1 reference

12 December 2020

Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin

1 reference

12 December 2020

Controlled trial for long-term low-dose erythromycin after sinus surgery for chronic rhinosinusitis

1 reference

12 December 2020